Stay updated on Olaparib in gBRCA Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Location blocks were expanded to include additional sites across multiple US states (Arizona, California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Missouri, New York, Ohio, Pennsylvania, Texas, Washington) and Canadian provinces (Ontario, Quebec). The page revision was updated to v3.3.3, with earlier blocks reorganized and the revision tag updated from v3.3.2.
    Difference
    0.9%
    Check dated 2025-12-24T15:20:39.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    29 days ago
    No Change Detected
  6. Check
    43 days ago
    Change Detected
    Summary
    Publications are described as automatically filled from PubMed with an updated Revision: v3.3.2. The previous note about PubMed publications and Revision: v3.2.0 has been removed.
    Difference
    0.1%
    Check dated 2025-11-24T17:03:47.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    - Removed the banner notice about government funding and NIH Clinical Center operating status; the page no longer displays that status information.
    Difference
    0.2%
    Check dated 2025-11-17T14:59:06.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The POLO study page content remains unchanged between the two screenshots. Core sections such as the title, study design, eligibility criteria, outcomes, and listed locations are the same.
    Difference
    0.2%
    Check dated 2025-11-03T01:30:48.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:34:29.000Z thumbnail image
  10. Check
    101 days ago
    Change Detected
    Summary
    Adds a new version label (v3.1.0) and removes multiple drug-related topics, indicating a restructuring and potential narrowing of content.
    Difference
    0.3%
    Check dated 2025-09-28T03:23:59.000Z thumbnail image

Stay in the know with updates to Olaparib in gBRCA Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.